Back to 
RHUMBLINE ADVISERS
RHUMBLINE ADVISERS
ACHNShowing 0 of 6 quarters
Position history for RHUMBLINE ADVISERS's holdings in ACHILLION PHARMACEUTICALS
As of its Q4 2019 13F, RhumbLine Advisers held 221,871 shares of ACHN (Achillion Pharmaceuticals), worth $1.3M. RhumbLine Advisers' 13F filings listed ACHN from Q4 2018 to Q4 2019, 5 quarterly filings.
Current Value
-
Current Shares
-
Total Value Change
$0
Total Shares Change
0
No position history available for this security.
Other major holders of ACHN: RTW INVESTMENTS, LP, DIMENSIONAL FUND ADVISORS LP, Pentwater Capital Management LP